From: Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2
Characteristic | 18-64 years N=99,483 | 65-79 years N=55,013 | ≥80 years N=26,032 | All patients N=170,528 | P value |
---|---|---|---|---|---|
Sex | Â | Â | Â | Â | < 0.001 |
 Women, % | 26.2 | 3.8 | 2.2 | 16.7 |  |
 Men, % | 73.8 | 96.2 | 97.8 | 83.3 |  |
Race | Â | Â | Â | Â | < 0.001 |
 White, % | 51.7 | 72.5 | 77.2 | 60.8 |  |
 Black, % | 23.4 | 18.3 | 12.8 | 20.8 |  |
 Other, % | 3.3 | 2.1 | 1.7 | 2.7 |  |
 Missing/Unknown | 21.5 | 7.1 | 8.3 | 15.6 |  |
Ethnicity | Â | Â | Â | Â | < 0.001 |
 Non-Hispanic | 69.4 | 89.6 | 89.7 | 77.8 |  |
 Hispanic | 11.9 | 6.3 | 5.3 | 9.5 |  |
 Missing/Unknown | 18.7 | 4.2 | 5 | 12.7 |  |
Body mass index (kg/m2) | Â | Â | Â | Â | < 0.001 |
 <18.5 (underweight), % | 0.4 | 1.2 | 2.7 | 0.9 |  |
 18.5-24.9 (normal weight), % | 9.9 | 16 | 33.4 | 14.1 |  |
 25.29.9 (overweight), % | 25.7 | 34.2 | 37.2 | 29.5 |  |
 30-34.9 (Obese I), % | 26.2 | 27.6 | 17.1 | 25.8 |  |
 ≥35 (Obese II and III), % | 23.4 | 19.4 | 6.2 | 20.5 |  |
 Missing, % | 14.5 | 1.6 | 3.4 | 9.3 |  |
Charlson Comorbidity Index (median (IQR)) | 0.0 (0.0,2.0) | 3.0 (2.0,6.0) | 4.0 (2.0,7.0) | 1.0 (0.0,4.0) | < 0.001 |
Charlson Comorbidity Index (%) | Â | Â | Â | Â | < 0.001 |
 0 | 54.6 | 11.2 | 8.8 | 36.3 |  |
 1 | 18.3 | 12 | 9.5 | 15.5 |  |
 2-3 | 16.4 | 27.5 | 24.2 | 20.7 |  |
 ≥4 | 10.7 | 49.3 | 57.5 | 27.6 |  |
Median (IQR) | 18-64 years | 65-79 years | ≥80 years | All patients | |
 Hospital LOS | 5 (3-9) | 7 (4-14) | 9 (5-15) | 7 (4-13) | |
 ICU (LOS) | 4 (2-8) | 5 (3-10) | 5 (2-9) | 5 (3-9) |